Wenfei Yu
Jinan, 250355, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Polydatin improves mitochondrial dynamics dysrhythmia by regulating BMAL1 to prevent and treat metabolic dysfunction-associated fatty liver disease.
Journal: Journal of ethnopharmacology
Published: March 17, 2026
Diosgenin Ameliorates Insulin Resistance in High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease Rats via the Adiponectin/ADIPOR1/APPL1 Pathway.
Journal: Journal of agricultural and food chemistry
Published: November 14, 2025
Genetic evidence for a causal relationship between 179 lipid species and cognitive function and alzheimer's disease: a bidirectional Mendelian randomization study.
Journal: European archives of psychiatry and clinical neuroscience
Published: April 07, 2025
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 23, 2024
Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive system.
Journal: The Journal of nutritional biochemistry
Published: August 26, 2024
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation.
Journal: Chemico-biological interactions
Published: August 21, 2024
Mechanism of action of Nrf2 and its related natural regulators in rheumatoid arthritis.
Journal: Journal of orthopaedic surgery and research
Published: July 25, 2024
Diosgenin ameliorating non-alcoholic fatty liver disease via Nrf2-mediated regulation of oxidative stress and ferroptosis.
Journal: Diabetes, obesity & metabolism
Published: June 06, 2024
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: April 24, 2024
Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway.
Journal: International immunopharmacology
Published: April 13, 2024
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway.
Journal: European journal of pharmacology
Published: March 23, 2024
Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy.
Journal: Frontiers in pharmacology
Published: January 02, 2024
Last Updated: 09/26/2026